* Chiron Corp., of Emeryville, Calif., and OrthoDiagnostic Systems Inc., of Raritan, N.J., entered into asettlement with Organon Teknika N.V., a company of theNetherlands-based Akzo Nobel Group, whereby Organonwill pay compensation for infringing Chiron's U.K. andEuropean hepatitis C virus patents.

* Corixa Corp., of Seattle, entered into a collaborationwith Belgium-based SmithKline Beecham Biologicals SAthat will provide Corixa committed, multi-year fundingfor its research into vaccines for infectious diseaseapplications. Neither terms not targets were disclosed.

* North American Vaccine Inc., of Beltsville, Md., wasissued a U.S. patent covering the manufacture of a proteinused in its conjugate vaccine for the prevention ofmeningitis.

* OraVax Inc., of Cambridge, Mass., received a notice ofpatent allowance covering the use of the monoclonal IgAantibody, HNK20, against respiratory syncytial virus.

* Pharmos Corp., of New York, received a notice ofallowance for a U.S. claim covering SubmicronEmulsions as an ocular drug delivery vehicle.

* Terrapin Technologies Inc., of South San Francisco,said in vivo studies of its myelostimulant, TER199,showed it accelerated the recovery of bone marrow cellsand speeded the reappearance of circulating neutrophils,platelets and lymphocytes following their suppression bycytotoxic agents.

(c) 1997 American Health Consultants. All rights reserved.